«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

28卷

期数:

2022年05期

页码:

525-529

栏目:

临床医学

出版日期:

2022-09-20

文章信息/Info

Title:

Effects of miR-132 and SMAD4 expression in peripheral blood of polycystic ovary syndrome on the proliferation and apoptosis of granulosa cells

文章编号:

1006-8147(2022)05-0525-05

作者:

董蕾; 史天云

（南阳市第一人民医院妇科，南阳 473200）

Author(s):

DONG Lei; SHI Tian-yun

（Department of Gynecology，Nanyang First People′s Hospital，Nanyang 473200，China）

关键词:

多囊卵巢综合征; 微小RNA-132; SMAD4蛋白; 颗粒细胞; 增殖; 凋亡

Keywords:

polycystic ovary syndrome; microRNA-132; SMAD4 protein; granulosa cell; proliferation;  apoptosis

分类号:

R711.75

DOI:

-

文献标志码:

A

摘要:

目的：探讨多囊卵巢综合征（PCOS）外周血中miR-132和SMAD4的表达水平及对卵巢颗粒细胞增殖和凋亡的影响。方法：收集2019年5月—2021年3月接受治疗的PCOS患者（PCOS组，85例），同时期来院就诊的月经规律的健康女性40名设为对照组。采用全自动生化分析仪检测黄体生成素（LH）、睾酮（T）、雄烯二酮和卵泡刺激素（FSH）的水平，qRT-PCR检测miR-132、SMAD4 mRNA相对表达水平，分析以上指标在两组间的差异及PCOS组中miR-132和SMAD4的相关性。分别将si-NC质粒、si-miR-132质粒、miR-NC质粒、SMAD4 mimic质粒和SMAD4 mimic+miR-132 mimic质粒转至KGN细胞中，MTT和流式细胞术分别检测转染细胞的增殖和凋亡。双荧光素酶报告实验检测miR-132和SMAD4靶向关系。结果：PCOS组LH、T、雄烯二酮和miR-132相对表达水平高于对照组，FSH和SMAD4 mRNA相对表达水平低于对照组（t=3.618、4.253、15.412、30.921、5.207、24.194，均P<0.05）。PCOS组中miR-132和SMAD4 mRNA的相对表达水平呈负相关（r=-0.876，P<0.001）。si-miR-132组中miR-132相对表达水平为0.58±0.07，低于si-NC组（2.68±0.24，t=5.201，P<0.001）。SMAD4 mimic组SMAD4 mRNA水平为1.89±0.21，高于miR-NC组（0.82±0.10）和SMAD4 mimic+ miR-132 mimic组（0.63±0.08，t=3.251、4.012，P<0.05）。si-miR-132组细胞增殖率（30.5±4.1）%低于si-NC组（65.3±4.8）%（t=8.512，P<0.001），细胞凋亡率（23.7±4.2）%高于si-NC组（5.7±1.8）%（t=7.625，P<0.001）。SMAD4 mimic组细胞增殖率（25.3±4.6）%低于miR-NC组（63.3±3.6）%和SMAD4 mimic+ miR-132 mimic组（63.7±5.8）%（t=3.210、3.515，P<0.05），细胞凋亡率（25.6±3.7）%，高于miR-NC组（6.3±2.0）%和SMAD4 mimic+ miR-132 mimic组（6.3±1.5）%（t=9.415、10.320，P<0.001）。miR-132与SMAD4存在靶向结合位点，miR-132可靶向调节SMAD4。结论：miR-132通过靶向调节SMAD4促进颗粒细胞的增殖并抑制其凋亡，可能参与PCOS的发病。

Abstract:

Objective：To detect the expression levels of miR-132 and SMAD4 in peripheral serum of polycystic ovary syndrome （PCOS），and analyze their effects on the proliferation and apoptosis of ovarian granulosa cells. Methods： A total of 85 patients with PCOS who received treatment in our hospital from May 2019 to March 2021 were collected as the PCOS group，and 40 healthy women with regular menstruation who came to the hospital during the same period were collected as the control group. An automatic biochemical analyzer was used to detect the levels of luteinizing hormone（LH），testosterone （T），and rostenedione and follicle stimulating hormone（FSH）. qRT-PCR was used to detect the relative expression levels of miR-132 and SMAD4 mRNA，and the above indicators differences were analyzed between the two groups and analyzed correlation of miR-132 and SMAD4 in the PCOS group.The si-NC plasmid，si-miR-132 plasmid，miR-NC plasmid，SMAD4 mimic plasmid and SMAD4 mimic+miR-132 mimic plasmid were transferred to KGN cells respectively，and the proliferation and apoptosis rate of transfected cells were detected by MTT and flow cytometry.The dual luciferase reporter experiment detected the targeting relationship between miR-132 and SMAD4. Results： The relative expression levels of LH，T，androstenedione and miR-132 in the PCOS group were higher than those in the control group，and the relative expression levels of FSH and SMAD4 mRNA were lower than those in the control group（t=3.618，4.253，15.412，30.921，5.207，24.194，all P<0.05）. The relative expression levels of miR-132 and SMAD4 mRNA in the PCOS group were negatively correlated（r=-0.876，P<0.001）.The relative expression level of miR-132 in si-miR-132 group was 0.58±0.07，which was lower than that in si-NC group（2.68±0.24，t=5.201，P<0.001）. The SMAD4 mRNA level in the SMAD4 mimic group was 1.89±0.21，which was higher than that in the miR-NC group（0.82±0.10） and the SMAD4 mimic+miR-132 mimic group（0.63±0.08）（t=3.251，4.012，P<0.05）.The cell proliferation rate in the si-miR-132 group was（30.5±4.1）%，which was lower than that in the si-NC group （65.3±4.8）%（t=8.512，P<0.001），and the apoptosis rate was （23.7±4.2）%，which was high than that in si-NC group（5.7±1.8）% （t=7.625，P<0.001）.The cell proliferation rate in the SMAD4 mimic group was（25.3±4.6）%，which was lower than that in the miR-NC group （63.3±3.6）% and the SMAD4 mimic+miR-132 mimic group （63.7±5.8）% （t=3.210，3.515，P<0.05） ，the apoptosis rate was （25.6±3.7）% higher than that in the miR-NC group （6.3±2.0）% and the SMAD4 mimic+miR-132 mimic group （6.3±1.5）% （t=9.415，10.320，P<0.001）. Conclusion：miR-132 promotes granulosa cell proliferation and inhibits apoptosis by targeting SMAD4，which may be involved in the pathogenesis of polycystic ovary syndrome.

参考文献/References:

[1] MEIER R K. Polycystic ovary syndrome[J]. Nurs Clin North Am，2018，53（3）：407-420.
[2] PENG S L，WU Q F，XIE Q，et al. PATL2 regulated the apoptosis of ovarian granulosa cells in patients with PCOS[J]. Gynecol Endocrinol，2021，37（7）：629-634.
[3] ZHANG J F，YU C M，YAN L L，et al. Effect of anti-mullerian hormone on stem cell factor in serum，follicular fluid and ovarian granular cells of polycystic ovarian syndrome patients[J]. Eur Rev Med Pharmacol Sci，2018，22（22）：7877-7882.
[4] RUPAIMOOLE R，SLACK F J. MicroRNA therapeutics： towards a new era for the management of cancer and other diseases[J]. Nat Rev Drug Discov，2017，16（3）：203-222.
[5] MISHRA S，YADAV T，RANI V. Exploring miRNA based approaches in cancer diagnostics and therapeutics[J]. Crit Rev Oncol Hematol，2016，98：12-23.
[6] BJORKMAN S，TAYLOR H S. MicroRNAs in endometriosis：biological function and emerging biomarker candidates[J].Biol Reprod，2019，100（5）：1135-1146.
[7] CHEN B，XU P，WANG J，et al. The role of MiRNA in polycystic ovary syndrome（PCOS）[J]. Gene，2019，706：91-96.
[8] WANG W，LI X，REN L，et al. MiR-132 relieves vascular endothelial inflammation and improve endothelial function in atherosclerosis rats by regulating SIRT1[J]. Minerva Endocrinol，2019，45：158-161.
[9] HAN Y，WANG F，SHAO L，et al.LncRNA TUG1 mediates lipopolysaccharide-induced proliferative inhibition and apoptosis of human periodontal ligament cells by sponging miR-132[J]. Acta Biochim Biophys Sin （Shanghai） ，2019，51： 1208-1215.
[10] ZHOU X，XIANG C，ZHENG X.miR-132 serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell viability[J]. Diagn Pathol，2019，14（1）：119.
[11] WU S，SUN H，ZHANG Q，et al.MicroRNA-132 promotes estradiol synthesis in ovarian granulosa cells via translational repression of Nurr1[J]. Reprod Biol Endocrinol，2015，13： 94.
[12] YAO G，YIN M，LIAN J，et al. MicroRNA-224 is involved in transforming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4[J]. Mol Endocrinol，2010，24（3）：540-551.
[13] 中华医学会妇产科学分会内分泌学组及指南专家组.多囊卵巢综合征中国诊疗指南[J].中华妇产科杂志，2018，53（1）：2-6.
[14] ZHANG F Y，ZHEN Y F，GUO Z X，et al. MiR-132/212 promotes the growth of precartilaginous stem cells（PCSCs） by regulating Ihh/PTHrP signaling pathway[J]. Biosci Rep，2020，40（5）：BSR20191654.
[15] MZIAUT H，HENNIGER G，GANSS K，et al. MiR-132 controls pancreatic beta cell proliferation and survival through Pten/Akt/Foxo3 signaling[J]. Mol Metab，2020，31：150-162.
[16] QAZI T J，LU J，DURU L，et al. Upregulation of mir-132 induces dopaminergic neuronal death via activating SIRT1/P53 pathway[J].Neurosci Lett，2021，740：135465.
[17] LI H，ZHANG P，LI F，et al. Plasma miR-22-5p，miR-132-5p，and miR-150-3p are associated with acute myocardial infarction[J]. Biomed Res Int，2019，2019：5012648.
[18] HUANG X，SHE L，LUO X，et al. MiR-222 promotes the progression of polycystic ovary syndrome by targeting p27 Kip1[J].Pathol Res Pract，2019，215（5）：918-923.

相似文献/References:

[1]李 江,王 刚.性激素结合球蛋白在多囊卵巢综合征患者中的变化及与其他指标的关系[J].天津医科大学学报,2016,22(04):325.
　LI Jiang,WANG Gang.Changes of SHBG in patients with polycystic ovary syndrome and their relationship with other indicators[J].Journal of Tianjin Medical University,2016,22(05):325.
[2]李英,张学军.miR-93在多囊卵巢综合征患者血清中的表达及临床意义[J].天津医科大学学报,2018,24(03):209.
　LI Ying,ZHANG Xue-jun.Expression and clinical significance of miR-93 in the serum of patients with polycystic ovary syndrome[J].Journal of Tianjin Medical University,2018,24(05):209.
[3]刘 娇,罗海宁,韩 莹,等.比较GnRH激动剂长方案与GnRH拮抗剂方案对LH/FSH比值大于等于2的多囊卵巢综合征患者临床结局影响[J].天津医科大学学报,2019,25(04):382.
　LIU Jiao,LUO Hai-ning,HAN Ying,et al.Effects of different GnRH-analogue on polycystic ovarian syndrome with LH/FSH ratioof 2 or higher[J].Journal of Tianjin Medical University,2019,25(05):382.
[4]邹怡欣,时雨杰综 述,刘 煜,等.多囊卵巢综合征与生物钟的研究进展[J].天津医科大学学报,2020,26(01):91.
[5]刘贝贝,刘伟靓,杜曲晓,等.血清miR-27a水平与多囊卵巢综合征及其临床特征的相关性[J].天津医科大学学报,2021,27(02):117.
　LIU Bei-bei,LIU Wei-liang,DU Qu-xiao,et al.Correlation of serum miR-27a level with polycystic ovarian syndrome and its clinical characteristics[J].Journal of Tianjin Medical University,2021,27(05):117.
[6]孙奎奎,杨微微,王文靖,等.多囊卵巢综合征关键基因的筛选及其与疾病进展和预后的相关性分析[J].天津医科大学学报,2023,29(06):609.
　SUN Kui-kui,YANG Wei-wei,WANG Wen-jing,et al.Screening of key genes in polycystic ovary syndrome and analysis of their correlation with disease progression and prognosis[J].Journal of Tianjin Medical University,2023,29(05):609.

备注/Memo

备注/Memo:

作者简介 董蕾（1980-），女，副主任医师，学士，研究方向：内分泌、产后康复；E-mail：xiaolei800906@163.com。

常用功能

更新日期/Last Update: 2022-09-20